|
CSNK2A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.96399596375363E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.39549499628333E-11 |
| Normal-vs-Stage2 |
5.030000E-02 |
| Normal-vs-Stage3 |
4.2172000000007E-05 |
| Normal-vs-Stage4 |
2.995500E-03 |
| Stage1-vs-Stage2 |
9.860100E-02 |
| Stage1-vs-Stage3 |
8.379800E-02 |
| Stage1-vs-Stage4 |
8.176600E-01 |
| Stage2-vs-Stage3 |
6.381600E-01 |
| Stage2-vs-Stage4 |
3.442800E-01 |
| Stage3-vs-Stage4 |
4.704200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92590388081726E-11 |
| Normal-vs-AfricanAmerican |
1.298430E-01 |
| Normal-vs-Asian |
1.257640E-03 |
| Caucasian-vs-AfricanAmerican |
4.268200E-02 |
| Caucasian-vs-Asian |
7.560200E-01 |
| AfricanAmerican-vs-Asian |
2.820000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25280008589357E-10 |
| Normal-vs-Female |
3.76120000000757E-06 |
| Male-vs-Female |
4.967800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.243860E-02 |
| Normal-vs-Age(41-60Yrs) |
1.18479670518923E-11 |
| Normal-vs-Age(61-80Yrs) |
3.64280000000328E-05 |
| Normal-vs-Age(81-100Yrs) |
4.008200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.663800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.964240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.658200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.736000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.815600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.616800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.484100E-02 |
| Normal-vs-Grade 2 |
7.58479945517365E-10 |
| Normal-vs-Grade 3 |
2.86050000020133E-07 |
| Normal-vs-Grade 4 |
2.554000E-02 |
| Grade 1-vs-Grade 2 |
7.751800E-01 |
| Grade 1-vs-Grade 3 |
6.444200E-01 |
| Grade 1-vs-Grade 4 |
5.119800E-01 |
| Grade 2-vs-Grade 3 |
5.512400E-01 |
| Grade 2-vs-Grade 4 |
3.083800E-01 |
| Grade 3-vs-Grade 4 |
5.172400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.48749917833402E-11 |
| Normal-vs-ccB subtype |
3.28500004975751E-09 |
| ccA subtype-vs-ccB subtype |
9.976000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95159999272221E-09 |
| Normal-vs-N1 |
7.269500E-02 |
| N0-vs-N1 |
4.235400E-01 |
|
|
